Hyaluronidase HYLASE “DESSAU” 150 IU
$51.00 / 0.0007 Ƀ
Hylase “Dessau” is THE ONLY injectable and free from the excipients Hyaluronidase.
Hylase “Dessau” is THE ONLY injectable and free from the excipients Hyaluronidase available in Europe. All the other European brands, such as for example, INNO-TDS are indicated for topical application for cellulite conditions.
Hyaluronic acid (HA)-based fillers are the most commonly used fillers. As the aesthetic market is growing, more and more patients will be treated with HA. With the increased involvement of sometimes inexperienced nurses and aesthetic practitioners the risk of unwanted results rises. Unwanted results can mean overcorrection and asymmetries as well as adverse events to these injectable fillers. Although hyaluronic-based fillers are defined as temporary materials, they can last up to 12 months or longer. Hyaluronidase destroys HA and gives the possibility to adjust overcorrection and asymmetries therefore can be considered as a rescue medication which can help reverse overcorrection or some more severe complications.
HYLASE “DESSAU” comes as a white powder which needs to be diluted with saline before injection.
Use HYLASE “DESSAU” to help reverse the results of hyaluronic acid injections. Based on a natural enzyme, this powder for solution can help reduce unwanted filling effect after a dermal filler treatment or reduce the severity of side effects by removing the gel. This cosmetic filler removal product, made by a trusted pharmaceutical company, can help give your clients peace of mind, knowing they will not have to put up with undesired dermal filler results.
Hyaluronidase is also indicated for injection-induced skin necrosis which is a rare but dreaded consequence of soft tissue augmentation with dermal fillers. It usually occurs as a result of injection of filler directly into an artery. A treatment with high doses of hyaluronidase (at least 200 U) is recommended. Additional hyaluronidase should be injected if improvement is not seen within 60 minutes.
One vial of HYLASE “DESSAU” contains 150 U. The 150-U vial is a safe and sufficient dose when used to remove 1 ml of unwanted deposits of hyaluronic acid. Any higher dose, for example, 1500 IU, requires a high level of professionalism and experience, otherwise it can easily damage the tissue. Besides, 1500 IU dose must be diluted with 10 ml of saline solution and used immediately after preparation. Any portion of the contents not used should be discarded which is a big waste of the product and money.
Hyaluronidase is an enzyme that breaks down HA (hyaluronan) by cleaving glycosidic bonds of HA and, to some extent, other acid mucopolysaccharides of the connective tissue. The enzyme is extracted from bovine testes. Most available hyaluronidase products use hyaluronidase of bovine origin, however, hyaluronidase of ovine origin exists as well.
INGREDIENTS OF HYLASE “DESSAU”
HYLASE “DESSAU” contains no preservatives and no excipients. It is a highly purified bovine protein extract with a low allergic or sensitizing potential. The bovine testes used in HYLASE “DESSAU” are obtained from New Zealand from a source which is recognized as being completely BSE (Bovine Spongiform Encephalopathy) free.
ADMINISTRATION OF HYLASE “DESSAU”
Before treatment with hyaluronidase HYLASE “DESSAU” it is advisable to do an allergy test.
First treatment should be done with low concentrated hyaluronidase by mixing 1 x 150 IU vial of HYLASE “DESSAU” with 1 ml of saline solution. Once the solution is prepared, inject the hyaluronidase into the affected area using a 30 gauge needle for superficial injections and 27 gauge for deeper deposits. Use 15 IU (0.1 ml) of a suspension per one injection point. For periorbital area only use 0,05 ml of the suspension. Wait for 48 hours to see the results.
If no improvement seen, do the treatment with a low concentration the second time.
If there is still no improvement, use higher concentrated hyaluronidase by mixing 1 x 150 IU vial of HYLASE “DESSAU” with only 0,5 ml of saline solution. Use 30 IU (0.1 ml of the suspension) per injection point.
Administration should be extremely accurate and limited to the affected area. In the case of nodules, they should be injected directly, and for product that has been injected into the superficial dermis, injections should be placed immediately into and below the product. During and after the procedure, it is recommended to massage the treated area quite vigorously to optimise the result and aid mechanical breakdown.
READ THE BELOW CAUTION BEFORE YOU BUY HYALURONIDASE INJECTION
Treatment in perioral and periorbital areas can cause swelling.
Ensure that the suspension is injected only into the affected areas.
The total treatment time must be no longer than one we